CoreCap Advisors »

Genes shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Genes (GCO) shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $299 7 42.71

More positions owned by CoreCap Advisors

Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Total Bond Market Etf Etf (BND)
Technology Select Sector Spdr Fund Etf (XLK)
Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Nvidia Corporation Stock (NVDA)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Apple Stock (AAPL)
Schwab U.s. Small-cap Etf Etf (SCHA)
Ishares Core S&p 500 Etf Etf (IVV)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Growth Etf Etf (VUG)
Invesco S&p 500 Equal Weight Etf Etf (RSP)

View all positions for CoreCap Advisors

Top funds holding Genes

Pzena Investment Management
Fund 1 Investments
BlackRock
Vanguard Group
Dimensional Fund Advisors
Acadian Asset Management
Morgan Stanley
Nomura Holdings
D. E. Shaw & Co
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Geode Capital Management
ING Groep
Healthcare Of Ontario Pension Plan Trust Fund

View all funds holding Genes